ApiFix

Startups, Entrepreneurs, Digital economy

Trendlines Group sells portfolio company ApiFix to Nasdaq-listed OrthoPediatrics Corp

Trendlines has exited portfolio company ApiFix, which focuses on non-fusion treatment of idiopathic scoliosis, particularly among adolescents.

Broker's Calls

NRA Capital says Trendlines is worth more than meets the eye

SINGAPORE (Nov 27): NRA Capital has found 11 “hidden gems” within Trendlines’ portfolio and derived a higher valuation of US$139 million ($187 million) or 22.5 cents per share.
×